Kraig Biocraft Laboratories (KBLB) Depreciation & Amortization (CF) (2010 - 2026)

Kraig Biocraft Laboratories has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $7602.0 in Q4 2025.

• Quarterly Depreciation & Amortization (CF) rose 25.61% year-over-year to $7602.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25114.0 (down 4.0% YoY) and the FY2025 annual result came in at $25113.0, down 4.0% from the prior year.
• Depreciation & Amortization (CF) advanced to $7602.0 in Q4 2025 per KBLB's latest filing, from $5992.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $7602.0 in Q4 2025 and troughed at $5683.0 in Q1 2025.
• A 5-year average of $6656.6 and a median of $6692.0 in 2021 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2021 and 2025: Depreciation & Amortization (CF) decreased 28.2% in 2021, then increased 25.61% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $6833.0 in 2021, then decreased by 2.44% to $6666.0 in 2022, then grew by 13.68% to $7578.0 in 2023, then declined by 20.14% to $6052.0 in 2024, then climbed by 25.61% to $7602.0 in 2025.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $7602.0, $5992.0, and $5837.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.